THRIVENT FINANCIAL FOR LUTHERANS – Regeneron Pharmaceuticals, Inc. Transaction History
THRIVENT FINANCIAL FOR LUTHERANS portfolio value:
$109.06M
portfolio value
THRIVENT FINANCIAL FOR LUTHERANS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +28.29% | 34.91K shares | 36.11M | $688.87 | 158.32K |
| Q2 2022 | share | Increase | +498.98% | 102.80K shares | 58.56M | $591.13 | 123.41K |
| Q1 2022 | share | Decrease | -61.11% | -32.38K shares | -19.07M | $698.42 | 20.60K |
| Q4 2021 | share | Decrease | -3.66% | -2.01K shares | 175K | $642.51 | 52.98K |
| Q3 2021 | share | Decrease | -0.36% | -200 shares | 2.45M | $605.18 | 54.99K |
| Q2 2021 | share | Increase | +42.81% | 16.54K shares | 12.54M | $558.54 | 55.19K |
| Q1 2021 | share | Decrease | -33.44% | -19.41K shares | -9.76M | $473.14 | 38.65K |
| Q4 2020 | share | Increase | +31.81% | 14.01K shares | 3.39M | $483.11 | 58.07K |
| Q3 2020 | share | Decrease | -2.30% | -1.03K shares | -3.46M | $559.78 | 44.05K |
| Q2 2020 | share | Increase | +1138.51% | 41.45K shares | 26.34M | $623.65 | 45.09K |
| Q1 2020 | share | 0.00% | 0 shares | 411K | $488.29 | 3.64K | |
| Q4 2019 | share | Increase | +0.33% | 12 shares | 360K | $375.48 | 3.64K |
| Q3 2019 | share | Increase | +2.78% | 98 shares | -98K | $277.4 | 3.62K |
| Q2 2019 | share | Increase | +0.89% | 31 shares | -332K | $313 | 3.53K |
| Q1 2019 | share | Increase | +3.52% | 119 shares | 174K | $410.62 | 3.5K |
| Q4 2018 | share | Increase | +1.78% | 59 shares | -79K | $373.5 | 3.38K |
| Q3 2018 | share | Increase | +2.28% | 74 shares | 221K | $404.04 | 3.32K |
| Q2 2018 | share | Increase | +1.06% | 34 shares | 14K | $344.99 | 3.24K |
| Q1 2018 | share | Increase | +2.72% | 85 shares | -69K | $344.36 | 3.21K |
| Q4 2017 | share | Increase | +3.61% | 109 shares | -174K | $375.96 | 3.12K |
| Q3 2017 | share | Increase | +5.96% | 170 shares | -50K | $447.12 | 3.02K |
| Q2 2017 | share | Increase | +2.15% | 60 shares | 319K | $491.14 | 2.85K |
| Q1 2017 | share | Increase | +6.49% | 170 shares | 119K | $387.51 | 2.79K |
| Q4 2016 | share | Increase | +6.50% | 160 shares | -27K | $367.09 | 2.62K |
| Q3 2016 | share | Decrease | -45.09% | -2.02K shares | -576K | $402.02 | 2.46K |
| Q2 2016 | share | Increase | +2.52% | 110 shares | -10K | $349.23 | 4.48K |
| Q1 2016 | share | Increase | +96.85% | 2.15K shares | 370K | $360.44 | 4.37K |